Evidence-based pharmacotherapy of treatment-resistant unipolar depression

M Dold, S Kasper - International journal of psychiatry in clinical …, 2017 - Taylor & Francis
Abstract Treatment resistance to the antidepressive pharmacotherapy represents one of the
most important clinical challenges in the pharmacological management of unipolar …

Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders

R Juza, K Musilek, E Mezeiova… - Medicinal Research …, 2023 - Wiley Online Library
Dopamine is a biologically active amine synthesized in the central and peripheral nervous
system. This biogenic monoamine acts by activating five types of dopamine receptors (D1 …

Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders-results from a European multicenter study

M Dold, L Bartova, D Souery, J Mendlewicz… - Journal of psychiatric …, 2017 - Elsevier
This naturalistic European multicenter study aimed to elucidate the association between
major depressive disorder (MDD) and comorbid anxiety disorders. Demographic and clinical …

Psychopharmaka

MJ Lohse, J Seifert, S Bleich - Arzneiverordnungs-Report 2021, 2021 - Springer
Zusammenfassung Auf einen Blick Zusammenfassung Mit weit über 2 Milliarden DDD
stellen die Psychopharmaka eine der größten Arzneimittelgruppen dar. Dabei sind die seit …

Potential biomarkers in psychiatry: focus on the cholesterol system

AG Woods, I Sokolowska, R Taurines… - Journal of cellular …, 2012 - Wiley Online Library
Abstract● Introduction● Methods for proteomic analysis–Sample fractionation/biochemical
fractionation–MS● The cholesterol system–Cholesterol and apolipoproteins–Cholesterol …

Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010

CJ Spindelegger, K Papageorgiou… - International journal …, 2015 - academic.oup.com
Abstract Background: Antidepressants (ADs) are known to have the potential to cause
various cardiovascular adverse drug reactions (ADRs). The tricyclic antidepressants (TCAs) …

Drug-induced liver injury during antidepressant treatment: results of AMSP, a drug surveillance program

ME Friedrich, E Akimova, W Huf… - International Journal …, 2016 - academic.oup.com
Background: Drug-induced liver injury is a common cause of liver damage and the most
frequent reason for withdrawal of a drug in the United States. The symptoms of drug-induced …

International union of basic and clinical pharmacology CIV: the neurobiology of treatment-resistant depression: from antidepressant classifications to novel …

F Caraci, F Calabrese, R Molteni, L Bartova… - Pharmacological …, 2018 - ASPET
Major depressive disorder is one of the most prevalent and life-threatening forms of mental
illnesses and a major cause of morbidity worldwide. Currently available antidepressants are …

[HTML][HTML] Preclinical and clinical sex differences in antipsychotic-induced metabolic disturbances: a narrative review of adiposity and glucose metabolism

LN Castellani, KA Costa-Dookhan… - Journal of psychiatry …, 2019 - ncbi.nlm.nih.gov
Antipsychotic (AP) medications are associated with an increased risk of developing
metabolic side effects including weight gain, type 2 diabetes (T2D), dyslipidemia, and …

7T ultra-high-field neuroimaging for mental health: an emerging tool for precision psychiatry?

I Neuner, T Veselinović, S Ramkiran… - Translational …, 2022 - nature.com
Given the huge symptom diversity and complexity of mental disorders, an individual
approach is the most promising avenue for clinical transfer and the establishment of …